Healthcare -
Biotechnology - NASDAQ - US
$ 2.45
6.52 %
$ 170 M
Market Cap
-0.79
P/E
IKT - CASH & EQUIVALENTS
Cash & Equivalents IKT - Inhibikase Therapeutics, Inc.
9.17 M
LAST VALUE
-52.58%
2 YEAR CAGR
89.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR